Tacrolimus ointment is a prescription medication used to treat moderate to severe atopic dermatitis (eczema) in adults and children age 2 and older. Sold under the brand name Protopic, it belongs to a class of drugs called calcineurin inhibitors, which calm the immune response in the skin rather than using steroids. It’s typically prescribed when other topical treatments haven’t worked well enough or aren’t a good fit.
Who It’s Approved For
The FDA approved tacrolimus ointment specifically as a second-line therapy. That means it’s not usually the first thing a doctor reaches for. It’s intended for people whose eczema didn’t improve enough with other topical prescriptions, or for situations where those treatments aren’t advisable, such as eczema on the face or other sensitive skin.
The ointment comes in two strengths: 0.03% and 0.1%. Children between ages 2 and 15 can only use the lower 0.03% concentration. Adults and teens 16 and older can use either strength. It is not approved for children under 2.
Off-Label Uses
Doctors also prescribe tacrolimus ointment for skin conditions beyond eczema. The American Academy of Dermatology notes that it’s used off-label for psoriasis, particularly plaque psoriasis on delicate areas like the face, genitals, armpits, and skin folds (inverse psoriasis). It’s also prescribed for vitiligo and lichen planus, among other inflammatory skin conditions. Off-label prescribing is common and perfectly legal when a doctor judges the medication appropriate for your situation.
How It Works
Eczema flares happen partly because immune cells in the skin overreact, triggering inflammation, redness, and itching. Tacrolimus works by blocking the activity of these immune cells, specifically the T-cells that drive the inflammatory cascade. By dialing down that overactive immune response directly in the skin, the ointment reduces swelling, redness, and itch without relying on steroids.
The Key Advantage Over Steroids
One of the biggest reasons doctors prescribe tacrolimus is that it doesn’t thin the skin. Topical steroids, especially when used repeatedly on the face, eyelids, or skin folds, can cause a condition called skin atrophy, where the skin becomes fragile and paper-thin over time. In a randomized trial comparing tacrolimus to the steroid betamethasone, the steroid reduced collagen production to roughly 17% of normal levels and decreased skin thickness by about 7 to 9%. Tacrolimus-treated skin, by contrast, maintained collagen production at approximately 100% of normal and showed no thinning at all.
This makes tacrolimus particularly valuable for eczema that appears on the face, around the eyes, on the neck, or in skin folds, areas where long-term steroid use carries the most risk.
What to Expect When You Start
Most people notice improvement within the first week of use. If your skin hasn’t gotten any better after two weeks, it’s worth talking to your doctor about other options. The ointment is meant for short-term treatment of flares and non-continuous long-term management, not for daily indefinite use. You apply a thin layer to affected skin twice a day, and once your skin clears, you stop.
The most common side effect is a burning or stinging sensation at the application site, especially during the first few days. This tends to fade as the skin heals and the barrier repairs itself. Some people also experience itching or redness early in treatment.
Precautions While Using It
Sun protection matters while you’re on tacrolimus. You should limit sun exposure, avoid tanning beds, and skip UV light therapy during treatment. When you’re outdoors, wear loose clothing over treated areas and use sunscreen. This applies even when the ointment isn’t actively on your skin.
Alcohol can cause an unexpected reaction. Some people experience facial flushing, redness, and a feeling of heat after drinking while using tacrolimus ointment. It’s not dangerous, but it can be uncomfortable and surprising if you’re not expecting it.
You can wear normal clothing over treated skin, but don’t cover the area with bandages, wraps, or occlusive dressings. These can increase how much of the drug your skin absorbs.
The Boxed Warning
Tacrolimus ointment carries an FDA boxed warning, the most serious type of safety alert. The warning notes a possible risk of cancer, including skin cancer and lymphoma, based on rare reports in patients using the drug. However, the FDA states that a direct causal link has not been established. The warning also notes that the long-term safety of tacrolimus ointment has not been fully determined. This is one reason the drug is positioned as a second-line treatment rather than a first choice, and why it’s recommended for short-term or intermittent use rather than continuous daily application over years.